VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

Hear from dynamic founders who are building successful businesses in innovative industries. As part of UNC's Insight and Action Series, this event will showcase the journeys and lessons learned by ...

In his talk, Dr. Perou will share his journey from research to entrepreneurship, highlighting the challenges and lessons learned in transforming his cancer genomics research into a successful startup ...

With advancements in drug development and new therapies, the FDA continuously updates its regulations to strengthen pharmacovigilance. From AI-driven adverse event detection to real-world evidence and ...

Many facilities across North Carolina support life sciences research. The listing covers core laboratory facilities at university and nonprofit research institutions that are open to researchers or ...

Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

Patients wanting easy access to their lab test results from LabCorp can now get them through their smart phones. The Burlington-based diagnostics and drug-development company said it has begun ...

Precision BioSciences, a Durham-based genome editing company, has created a new name and brand identity for its food and agriculture business: Elo Life Systems. “Through Elo Life Systems, we continue ...

Durham-based Mycovia Pharmaceuticals, formerly Viamet Pharmaceuticals, has begun two Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women. The trials ...

GreenLight Biosciences, Inc., a Boston-based agtech company with lab, office and greenhouse space in RTP, has closed a Series C funding round, including a $25 million investment from a new investor, ...

Clinical trials are at a crossroads. This talk will explore the shift from viewing patients as mere subjects to recognizing them as essential partners in research. Attendees will gain insights into ...